Scotland's national naloxone program: The prison experience

Drug Alcohol Rev. 2018 May;37(4):454-456. doi: 10.1111/dar.12542. Epub 2017 Apr 10.

Abstract

Launched in 2011, the Scottish national naloxone program marked an important development in public health policy. Central to its design were strategies to engage prisoners given their elevated risk of drug-related death in the weeks following liberation. Implementation across Scottish prisons has posed particular challenges linked to both operational issues within prison establishments and individual factors affecting staff delivering, and prisoners engaging, with the program. Barriers have been overcome through innovation and partnership working. This commentary has described how the development of the program in prisons has adapted to these challenges to a point where a largely consistent model is in place and where prisoners-on-release are reaping the benefits in terms of reduced opioid-related mortality.

Keywords: mortality; naloxone; overdose; prison.

MeSH terms

  • Drug Overdose / drug therapy*
  • Harm Reduction*
  • Humans
  • Naloxone / therapeutic use*
  • Narcotic Antagonists / therapeutic use*
  • Prisoners
  • Prisons*
  • Scotland

Substances

  • Narcotic Antagonists
  • Naloxone